Počet záznamov: 1

pioglitazón

SYS		d000077205
LBL		00000cz--a2200181n--4500
005		20250606222639.0
008		190101\|\|\|anznnbabn-----------\|-a\|a------
040		$b slo $a BA006 $d BA006 $d BA006 $d BA006
065		$a D02.886.675.933.250
065		$a D03.383.129.708.933.250
066		$a 01 $c 03
150		$a pioglitazón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo
450		$w v $a Pioglitazone Hydrochloride $2 eng
450		$w v $a 5-(4-(2-(5-etyl-2-pyridyl)etoxy)benzyl)-2,4-tiazolidíndión $2 slo
450		$w v $a Actos $2 slo
450		$w v $a pioglitazón hydrochlorid $2 slo
550		$7 sllk_us_auth*d000077154 $Y Rosiglitazone $w b $a rosiglitazón
550		$7 sllk_us_auth*d007004 $Y Hypoglycemic Agents $w P $a hypoglykemiká
550		$7 sllk_us_auth*d000077154 $Y Rosiglitazone $w p $a rosiglitazón
665		$a 2019 (1989) $2 eng
680	9-	$i A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. $2 eng
750	-2	$a Pioglitazone $2 eng
980		$x M

Počet záznamov: 1